Pariem Tablet 10 mg (Empagliflozin)
Empagliflozin 10mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.
MFDS item code 202102095 · Approved 2021.03.05
Improvement of glycemic control in adults with type 2 diabetes
This medication is used in conjunction with dietary and exercise therapy to help adults with type 2 diabetes manage their blood sugar levels. It can be taken alone or in combination with metformin, pioglitazone, sulfonylureas, insulin, or the DPP-4 inhibitor linagliptin if blood sugar is not adequately controlled with existing therapies. In particular, for patients with accompanying cardiovascular diseases, caution regarding the occurrence of cardiovascular events should be observed as per a specialist's advice. This medication effectively improves blood sugar control and is used to assist in managing diabetes.
The recommended dose of this drug is 10 mg once daily for monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this drug is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this drug is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia This drug may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose on the same day. No dose adjustment is necessary for patients with mild renal impairment. Treatment with this drug should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this drug well but have a persistent eGFR < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This drug should be discontinued if the eGFR decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this drug in patients with end-stage renal disease (ESRD) or who are on dialysis, as efficacy is not expected. No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this drug is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years and older. Initiation of this drug is not recommended in adults aged 85 years and older because clinical experience is limited
This medication should not be administered to certain patients. For example, patients with allergies to the active ingredient or components of this medication, patients with type 1 diabetes or diabetic ketoacidosis, patients with severely impaired kidney function, and those with genetic issues such as lactose intolerance or galactose absorption problems should not use this medication. In patients with moderately impaired kidney function, caution should be exercised, and if kidney function continues to deteriorate, discontinuation of this medication may be necessary. This medication is not expected to be effective in patients with end-stage renal disease or those undergoing dialysis. In patients with heart failure, especially those with mild to moderate cases, careful use is advised, and it is not recommended for severe heart failure patients. This medication may increase the risk of hypoglycemia when used with insulin or sulfonylureas, thus necessitating dose adjustments of these medications. While taking this medication, patients should carefully monitor for symptoms such as hypoglycemia, urinary tract infections, genital infections, increased urination, and decreased fluid volume. Especially, there is a risk of metabolic acidosis known as ketoacidosis, so if symptoms such as nausea, vomiting, abdominal pain, or difficulty breathing occur, immediate consultation with medical personnel is necessary. Elderly patients, especially those over 75 years of age, are at an increased risk of fluid volume loss, and caution is required when using this medication. This medication may affect kidney function, so regular kidney function tests are recommended. Additionally, this medication may have a mild impact when driving or operating machinery, so caution should be taken, especially in cases where there is a risk of hypoglycemia. Pregnant or breastfeeding women are advised to avoid taking this medication and should discontinue use upon confirmation of pregnancy. Safety and efficacy in children and adolescents under 18 years of age have not been established. No specific toxic symptoms have been reported in cases of overdose, but appropriate treatment may be required depending on the clinical condition. Lastly, this medication should be stored out of reach of children, and transferring it to another container may affect its quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air or moisture and is best kept at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the medication's efficacy and safety.
Pale yellow, double-convex, round film-coated tablet
30 tablets / bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 10mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Korea Prime Pharmaceuticals Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.